Literature DB >> 2785662

Influence of the central nucleus of the amygdala on the content of corticotropin-releasing factor in the median eminence.

S Beaulieu1, G Pelletier, H Vaudry, N Barden.   

Abstract

The central nucleus of the amygdala possesses numerous neurons containing corticotropin-releasing factor (CRF). This study demonstrates a striking decrease of the CRF-like immunoreactivity in the median eminence at both 1 and 2 weeks after bilateral lesions of the amygdaloid central nucleus. Lesion of the amygdaloid central nucleus did not alter the neurophysin-like immunoreactivity in the internal zone of the median eminence, indicating the integrity of the efferent neurophysin-containing fibers of the supraoptic and paraventricular hypothalamic nuclei. However, there was a concomitant decrease of neurophysin and CRF-like immunoreactivity in the external zone of the median eminence. These results substantiate the hypothesis that the amygdaloid central nucleus can influence the content of CRF-like material in the median eminence via a multisynaptic pathway involving the synthesis of CRF at the level of the paraventricular nucleus of the hypothalamus. The exact mechanism by which lesion of the amygdaloid central nucleus influences the CRF content in the median eminence remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785662     DOI: 10.1159/000125125

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  13 in total

1.  Neuroplasticity of the hypothalamic-pituitary-adrenal axis early in life requires recurrent recruitment of stress-regulating brain regions.

Authors:  Kristina A Fenoglio; Yuncai Chen; Tallie Z Baram
Journal:  J Neurosci       Date:  2006-03-01       Impact factor: 6.167

2.  Down-regulation of hypothalamic corticotropin-releasing hormone messenger ribonucleic acid (mRNA) precedes early-life experience-induced changes in hippocampal glucocorticoid receptor mRNA.

Authors:  S Avishai-Eliner; M Eghbal-Ahmadi; E Tabachnik; K L Brunson; T Z Baram
Journal:  Endocrinology       Date:  2001-01       Impact factor: 4.736

Review 3.  Neurobiology of the stress response early in life: evolution of a concept and the role of corticotropin releasing hormone.

Authors:  K L Brunson; S Avishai-Eliner; C G Hatalski; T Z Baram
Journal:  Mol Psychiatry       Date:  2001-11       Impact factor: 15.992

4.  Lesions of the central amygdala and ventromedial medulla reduce bladder hypersensitivity produced by acute but not chronic foot shock.

Authors:  Alan Randich; Cary DeWitte; Jennifer J DeBerry; Meredith T Robbins; Timothy J Ness
Journal:  Brain Res       Date:  2017-09-01       Impact factor: 3.252

5.  Regulation of corticosteroid receptor gene expression in depression and antidepressant action.

Authors:  N Barden
Journal:  J Psychiatry Neurosci       Date:  1999-01       Impact factor: 6.186

Review 6.  Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits.

Authors:  J Raber
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

Review 7.  Stress and the developing hippocampus: a double-edged sword?

Authors:  Kristen L Brunson; Yuncai Chen; Sarit Avishai-Eliner; Tallie Z Baram
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

Review 8.  Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression.

Authors:  Nicholas Barden
Journal:  J Psychiatry Neurosci       Date:  2004-05       Impact factor: 6.186

9.  Corticotropin releasing factor mRNA expression in the hypothalamic paraventricular nucleus and the central nucleus of the amygdala is modulated by repeated acute stress in the immature rat.

Authors:  C G Hatalski; C Guirguis; T Z Baram
Journal:  J Neuroendocrinol       Date:  1998-09       Impact factor: 3.627

10.  Brain activation in response to visceral stimulation in rats with amygdala implants of corticosterone: an FMRI study.

Authors:  Anthony C Johnson; Brent Myers; Jelena Lazovic; Rheal Towner; Beverley Greenwood-Van Meerveld
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.